Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials.

Int J Clin Pract · 2015 · PMC4383643 · PMID 25496316

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For trial 205.458 alone, the shift tables for absence/presence of VPB runs off treatment/on treatment showed a trend for differences between the lower (1.25, 2.5 μg) and higher (5 μg) tiotropium Respimat® doses.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.